An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs).

about

An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs).

Item

http://www.wikidata.org/entity/Q52659191

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

An innovative mesothelioma tre ...... argeted minicells (TargomiRs).

@en

An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells

@nl

type

Item

label

An innovative mesothelioma tre ...... argeted minicells (TargomiRs).

@en

An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells

@nl

prefLabel

An innovative mesothelioma tre ...... argeted minicells (TargomiRs).

@en

An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells

@nl

P1476

An innovative mesothelioma tre ...... argeted minicells (TargomiRs).

@en

P2093

Santiago Viteri

http://www.w3.org/2001/XMLSchema#string

P2860

Malignant Mesothelioma: Global Incidence and Relationship with Asbestos

Overcoming cellular barriers for RNA therapeutics.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Physiological and pathological roles for microRNAs in the immune system.

Minicells: versatile vectors for targeted drug or si/shRNA cancer therapy.

MiRNA-based therapeutic intervention of cancer.

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma

P304

S1-S4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/TLCR.2017.12.01

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rafael Rosell

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29531894

http://www.w3.org/2001/XMLSchema#string

P932

5835633

http://www.w3.org/2001/XMLSchema#string